Bionano Genomics Reports First Quarter 2021 Financial Results and Highlights Recent Business Progress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Bionano Genomics Reports First Quarter 2021 Financial Results and Highlights Recent Business Progress
May 13, 2021 16:01 ET | Source: Bionano Genomics Bionano Genomics San Diego, California, UNITED STATES
179% year-over-year revenue increase driven by record sales of consumables and growth in the Saphyr installed base
All 2021 milestones on track
Strong balance sheet with $362 million cash as of March 31, 2021
Conference call today, Thursday, May 13, at 4:30 pm ET
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE)
Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the first quarter ended March 31, 2021 and highlighted recent corporate updates.
“2021 is off to a solid start for Bionano. In the first quarter, we sold a record number of flow cells, analyzed a record number of samples in our service lab, drove broad adoption of Saphyr instruments and ramped up the installation of Sa
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Presentation Recordings from Bionano’s Next-Generation Cytogenomics Symposium, its Most .
Bionano GenomicsFebruary 5, 2021 GMT
SAN DIEGO, Feb. 05, 2021 (GLOBE NEWSWIRE) Bionano Genomics, Inc. (Nasdaq: BNGO) announced that presentation recordings from its 5-day Next-Generation Cytogenomics Symposium, which took place from January 11 to 15 and featured 33 presentations by Saphyr users, are now available online on the company’s website and its YouTube page. This event was by far its highest attended to date, with more than 15,500 session registrations and more than 6,400 session views from around the world. With the presentation recordings now available online, the impact of the event can continue to grow and expand awareness of Bionano Genomics and its Saphyr system for optical genome mapping and structural variation analysis.
Day Five of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Identifies Structural Variants that May Predispose to Severe COVID-19 Illness
January 18, 2021 19:00 ET | Source: Bionano Genomics Bionano Genomics San Diego, California, UNITED STATES
COVID-19 Host Genome Structural Variant (SV) Consortium used Saphyr to identify SVs in severe COVID-19 patients that affect genes involved in immunity, airway mucous, and viral replication
SVs found by several investigators point to a central role for disease severity of the interferon response pathway
Consortium has added investigators from Augusta University, Boston Children’s Hospital, New York Genome Center, Radboud University, Rockefeller University, UC San Diego, Virginia Commonwealth University, and two dozen other institutes from around the world